全文获取类型
收费全文 | 16795篇 |
免费 | 1373篇 |
国内免费 | 743篇 |
专业分类
耳鼻咽喉 | 230篇 |
儿科学 | 239篇 |
妇产科学 | 118篇 |
基础医学 | 891篇 |
口腔科学 | 185篇 |
临床医学 | 1750篇 |
内科学 | 3573篇 |
皮肤病学 | 21篇 |
神经病学 | 614篇 |
特种医学 | 455篇 |
外国民族医学 | 23篇 |
外科学 | 2630篇 |
综合类 | 3199篇 |
现状与发展 | 3篇 |
预防医学 | 541篇 |
眼科学 | 37篇 |
药学 | 945篇 |
8篇 | |
中国医学 | 320篇 |
肿瘤学 | 3129篇 |
出版年
2024年 | 22篇 |
2023年 | 287篇 |
2022年 | 393篇 |
2021年 | 667篇 |
2020年 | 656篇 |
2019年 | 582篇 |
2018年 | 543篇 |
2017年 | 611篇 |
2016年 | 754篇 |
2015年 | 698篇 |
2014年 | 1210篇 |
2013年 | 1127篇 |
2012年 | 1068篇 |
2011年 | 1114篇 |
2010年 | 857篇 |
2009年 | 841篇 |
2008年 | 842篇 |
2007年 | 871篇 |
2006年 | 819篇 |
2005年 | 698篇 |
2004年 | 611篇 |
2003年 | 451篇 |
2002年 | 414篇 |
2001年 | 373篇 |
2000年 | 316篇 |
1999年 | 242篇 |
1998年 | 244篇 |
1997年 | 222篇 |
1996年 | 142篇 |
1995年 | 172篇 |
1994年 | 162篇 |
1993年 | 104篇 |
1992年 | 120篇 |
1991年 | 133篇 |
1990年 | 85篇 |
1989年 | 81篇 |
1988年 | 43篇 |
1987年 | 46篇 |
1986年 | 41篇 |
1985年 | 46篇 |
1984年 | 35篇 |
1983年 | 28篇 |
1982年 | 38篇 |
1981年 | 24篇 |
1980年 | 25篇 |
1979年 | 15篇 |
1978年 | 9篇 |
1977年 | 11篇 |
1976年 | 8篇 |
1975年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 968 毫秒
1.
2.
3.
目的探讨接受选择性淋巴结照射(ENI)的食管鳞癌患者预后和失败模式。方法回顾性分析2005年1月至2012年12月河北医科大学第四医院收治的179例符合入组条件的食管鳞癌患者,分析肿瘤局部相关因素预测患者预后的价值,分析影响患者近期疗效、预后的影响因素,并对影响患者总生存率(OS)、无进展生存率(PFS)和复发的指标分别进行单因素和多因素分析。结果全组患者1、3、5年OS和PFS分别为77.1%、40.1%、26.0%和62.6%、30.6%、20.3%。多因素分析结果显示声音嘶哑、cN分期、cTNM分期、GTV-横径(GTV-D)和GTV-体积/长度(GTV-V/L)为影响患者OS的独立性影响因素(P<0.05);声音嘶哑、cTNM分期和近期疗效为影响患者PFS的独立性影响因素(P<0.05)。全组有75例(41.9%)患者出现复发,61例(34.1%)远处转移,其中19例(10.6%)为合并复发和远处转移。75例复发患者中64例(85.3%)患者为单纯食管复发,4例(5.3%)为单纯淋巴结复发,另7例(9.3%)患者为食管合并淋巴结复发。治疗后达完全缓解(CR)的63例患者中有18例患者出现复发,其中仅有2例患者出现淋巴结复发;logistic多因素分析结果显示患者周边组织/器官受侵、GTV-D和近期疗效为影响患者复发的独立性影响因素(P<0.05)。结论食管鳞癌患者接受ENI确实可行,其失败主要模式仍为食管复发;治疗前声音嘶哑、GTV-D和GTV-V/L较大、临床分期较晚和近期疗效不佳为患者预后较差的指标;肿瘤周边组织受侵、GTV-D和近期疗效是影响患者失败的独立性因素。 相似文献
4.
5.
6.
7.
Harit Kapoor Kush Raj Lohani Tommy H. Lee Devendra K. Agrawal Sumeet K. Mittal 《CTS Clinical and Translational Science》2015,8(6):841-847
Esophageal adenocarcinoma is the fastest rising cancer in the United States. It develops from long‐standing gastroesophageal reflux disease which affects >20% of the general population. It carries a very poor prognosis with 5‐year survival <20%. The disease is known to sequentially progress from reflux esophagitis to a metaplastic precursor, Barrett''s esophagus and then onto dysplasia and esophageal adenocarcinoma. However, only few patients with reflux develop Barrett''s esophagus and only a minority of these turn malignant. The reason for this heterogeneity in clinical progression is unknown. To improve patient management, molecular changes which facilitate disease progression must be identified. Animal models can provide a comprehensive functional and anatomic platform for such a study. Rats and mice have been the most widely studied but disease homology with humans has been questioned. No animal model naturally simulates the inflammation to adenocarcinoma progression as in humans, with all models requiring surgical bypass or destruction of existing antireflux mechanisms. Valuable properties of individual models could be utilized to holistically evaluate disease progression. In this review paper, we critically examined the current animal models of Barrett''s esophagus, their differences and homologies with human disease and how they have shaped our current understanding of Barrett''s carcinogenesis. 相似文献
8.
目的:探讨三种不同引流方式对食管癌术后颈部吻合口瘘的引流效果。方法:收集从2013年1月到2016年9月在我科行食管癌手术并术后发生颈部吻合口瘘患者,比较入组患者所采用的不同颈部引流方式的优劣。结果:共有83例患者纳入研究,有34例进入A组,行纱布条引流组;28例进入B组,行造瘘袋引流组;21例进入C组,行胃管负压引流组。所有入组患者一般资料和手术资料对比无明显统计学差异(P>0.05)。观察指标对比结果显示,C组患者瘘口愈合时间较其他两组时间短[(15.90±4.18)天vs(14.60±4.41)天vs(9.65±3.80)天],住院时间较其他两组短[(18.10±4.17)天vs(16.20±3.78)天vs(12.30±3.29)天],换药次数较其他两组少[(37.55±8.75)天vs(14.5±3.23)天vs(10.00±2.05)天],抗生素使用时间也较其他组明显减少[(13.10±2.49)天vs(10.85±1.84)天vs(7.20±1.74)天]。结论:颈部放置负压引流有助于食管癌术后颈部吻合口瘘愈合,值得临床推广与进一步研究。 相似文献
9.
《European annals of otorhinolaryngology, head and neck diseases》2019,136(3):173-177
IntroductionRetropharyngeal lipostructure is a recent procedure in velopharyngeal insufficiency (VPI), offering an effective alternative to heavier surgery.ObjectivesTo update and assess retropharyngeal lipostructure as a treatment for VPI in the University Hospital Center of Rouen (France).Type of studySingle-center prospective study, from May 2012 to May 2014.Patients and methodsSix patients (4 girls, 2 boys) presenting with VPI were treated by retropharyngeal lipostructure. Age at surgery ranged between 6 and 12 years. Four of the patients bore a 22q11 microdeletion. Treatment was indicated in case of Borel-Maisonny type 2b (n = 2) or 2 m (n = 4) despite well-conducted speech therapy and of ≥ 50% velopharyngeal sphincter closure on nasal endoscopy. Patients were assessed preoperatively and at 3 months, by a multidisciplinary team. Borel-Maisonny type was assessed by a speech therapist. Nasality was measured on assisted vocal evaluation (EVA®). Sphincter closure was assessed on dynamic MRI.ResultsBetween 6 and 8 cm3autologous fat was injected. At 3 months, 4 children showed 1-grade improvement in Borel-Maisonny type. Nasality decreased systematically, from a mean 14.5% preoperatively to 10.5% postoperatively. MRI showed improvement in all cases, with complete closure in occlusive vowels in 3 children.ConclusionEVA® and MRI provide precise objective assessment of VPI. Retropharyngeal lipostructure is a simple, relatively non-invasive, reproducible technique, providing good results in VPI. 相似文献
10.
Background:Gastrointestinal complications and malnutrition are common problems that affect postoperative rehabilitation and survival of patients with esophageal cancer. Evidence has shown that probiotics have a positive effect on improving gastrointestinal complications and nutritional status of patients with esophageal cancer after surgery, but there is a lack of prospective studies on this topic. We designed this prospective randomized controlled trial to evaluate the effects of probiotics on gastrointestinal complications and nutritional status in patients with postoperative esophageal cancer.Methods:This is a prospective, randomized, double-blind, placebo-controlled trial. It was approved by the Clinical Research Ethics Committee of our hospital. 192 patients will be randomly divided into probiotics group and the placebo group in a 1:1 ratio. After operation, probiotics and placebo will be given orally for 8 weeks. The indexes of nutritional status and incidence of digestive tract complications will be recorded and the data will be analyzed by SPSS 18.0 software.Discussion:This study will evaluate the effect of probiotics on gastrointestinal complications and nutritional status of postoperative patients with esophageal cancer. The results of this study will provide clinical basis for the use of probiotics in postoperative treatment of esophageal cancer.Trial registration:OSF Registration number: D DOI 10.17605/OSF.IO/QHW86 相似文献